Keywords: Dr Reddy's, R-Pharm, Russia, Manufacturing, Marketing, Indian plant

India’s Dr Reddy’s collaborates with Russia’s R-Pharm; gas leak at Bollaram API plant

Article | 23 December 2010

Print This

India’s second largest drugmaker Dr Reddy’s Laboratories (NYSE: RDY) has entered into a licensing, technology transfer, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in